Catalyst Wire Dossier Catalyst Wire Dossier

CUVRIOR

trientine tetrahydrochloride · Orphalan SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CUVRIOR, covering 2022-04-28 to 2022-04-28. Get the full timeline:

Most recent: FDA Approved: CUVRIOR — Original Application (Orphalan SA)

See pricing